Literature DB >> 19001870

When more is less: excess and deficiency of autophagy coexist in skeletal muscle in Pompe disease.

Nina Raben1, Rebecca Baum, Cynthia Schreiner, Shoichi Takikita, Noboru Mizushima, Evelyn Ralston, Paul Plotz.   

Abstract

The role of autophagy, a catabolic lysosome-dependent pathway, has recently been recognized in a variety of disorders, including Pompe disease, which results from a deficiency of the glycogen-degrading lysosomal hydrolase acid-alpha glucosidase (GAA). Skeletal and cardiac muscle are most severely affected by the progressive expansion of glycogen-filled lysosomes. In both humans and an animal model of the disease (GAA KO), skeletal muscle pathology also involves massive accumulation of autophagic vesicles and autophagic buildup in the core of myofibers, suggesting an induction of autophagy. Only when we suppressed autophagy in the skeletal muscle of the GAA KO mice did we realize that the excess of autophagy manifests as a functional deficiency. This failure of productive autophagy is responsible for the accumulation of potentially toxic aggregate-prone ubiquitinated proteins, which likely cause profound muscle damage in Pompe mice. Also, by generating muscle-specific autophagy-deficient wild-type mice, we were able to analyze the role of autophagy in healthy skeletal muscle.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19001870      PMCID: PMC3257549          DOI: 10.4161/auto.5.1.7293

Source DB:  PubMed          Journal:  Autophagy        ISSN: 1554-8627            Impact factor:   16.016


  22 in total

1.  LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing.

Authors:  Y Kabeya; N Mizushima; T Ueno; A Yamamoto; T Kirisako; T Noda; E Kominami; Y Ohsumi; T Yoshimori
Journal:  EMBO J       Date:  2000-11-01       Impact factor: 11.598

Review 2.  Development by self-digestion: molecular mechanisms and biological functions of autophagy.

Authors:  Beth Levine; Daniel J Klionsky
Journal:  Dev Cell       Date:  2004-04       Impact factor: 12.270

3.  Lysosomal turnover, but not a cellular level, of endogenous LC3 is a marker for autophagy.

Authors:  Isei Tanida; Naoko Minematsu-Ikeguchi; Takashi Ueno; Eiki Kominami
Journal:  Autophagy       Date:  2005-07-31       Impact factor: 16.016

4.  Loss of autophagy in the central nervous system causes neurodegeneration in mice.

Authors:  Masaaki Komatsu; Satoshi Waguri; Tomoki Chiba; Shigeo Murata; Jun-ichi Iwata; Isei Tanida; Takashi Ueno; Masato Koike; Yasuo Uchiyama; Eiki Kominami; Keiji Tanaka
Journal:  Nature       Date:  2006-04-19       Impact factor: 49.962

5.  Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice.

Authors:  Taichi Hara; Kenji Nakamura; Makoto Matsui; Akitsugu Yamamoto; Yohko Nakahara; Rika Suzuki-Migishima; Minesuke Yokoyama; Kenji Mishima; Ichiro Saito; Hideyuki Okano; Noboru Mizushima
Journal:  Nature       Date:  2006-04-19       Impact factor: 49.962

6.  Dysfunction of endocytic and autophagic pathways in a lysosomal storage disease.

Authors:  Tokiko Fukuda; Lindsay Ewan; Martina Bauer; Robert J Mattaliano; Kristien Zaal; Evelyn Ralston; Paul H Plotz; Nina Raben
Journal:  Ann Neurol       Date:  2006-04       Impact factor: 10.422

7.  Replacing acid alpha-glucosidase in Pompe disease: recombinant and transgenic enzymes are equipotent, but neither completely clears glycogen from type II muscle fibers.

Authors:  Nina Raben; Tokiko Fukuda; Abigail L Gilbert; Deborah de Jong; Beth L Thurberg; Robert J Mattaliano; Peter Meikle; John J Hopwood; Kunio Nagashima; Kanneboyina Nagaraju; Paul H Plotz
Journal:  Mol Ther       Date:  2005-01       Impact factor: 11.454

Review 8.  Autophagosome formation in mammalian cells.

Authors:  Noboru Mizushima; Yoshinori Ohsumi; Tamotsu Yoshimori
Journal:  Cell Struct Funct       Date:  2002-12       Impact factor: 2.212

9.  Impairment of starvation-induced and constitutive autophagy in Atg7-deficient mice.

Authors:  Masaaki Komatsu; Satoshi Waguri; Takashi Ueno; Junichi Iwata; Shigeo Murata; Isei Tanida; Junji Ezaki; Noboru Mizushima; Yoshinori Ohsumi; Yasuo Uchiyama; Eiki Kominami; Keiji Tanaka; Tomoki Chiba
Journal:  J Cell Biol       Date:  2005-05-02       Impact factor: 10.539

10.  Autophagic degradation of glycogen in skeletal muscles of the newborn rat.

Authors:  S Schiaffino; V Hanzlíková
Journal:  J Cell Biol       Date:  1972-01       Impact factor: 10.539

View more
  22 in total

1.  Storage vesicles in neurons are related to Golgi complex alterations in mucopolysaccharidosis IIIB.

Authors:  Sandrine Vitry; Julie Bruyère; Michaël Hocquemiller; Stéphanie Bigou; Jérôme Ausseil; Marie-Anne Colle; Marie-Christine Prévost; Jean Michel Heard
Journal:  Am J Pathol       Date:  2010-10-29       Impact factor: 4.307

2.  The role of autophagy in the pathogenesis of glycogen storage disease type II (GSDII).

Authors:  A C Nascimbeni; M Fanin; E Masiero; C Angelini; M Sandri
Journal:  Cell Death Differ       Date:  2012-05-18       Impact factor: 15.828

3.  Salmeterol with Liver Depot Gene Therapy Enhances the Skeletal Muscle Response in Murine Pompe Disease.

Authors:  Sang-Oh Han; Songtao Li; Jeffrey I Everitt; Dwight D Koeberl
Journal:  Hum Gene Ther       Date:  2019-04-05       Impact factor: 5.695

Review 4.  Pros and cons of different ways to address dysfunctional autophagy in Pompe disease.

Authors:  Jeong-A Lim; Naresh Kumar Meena; Nina Raben
Journal:  Ann Transl Med       Date:  2019-07

Review 5.  Pompe Disease: From Basic Science to Therapy.

Authors:  Lara Kohler; Rosa Puertollano; Nina Raben
Journal:  Neurotherapeutics       Date:  2018-10       Impact factor: 7.620

6.  Doxorubicin Blocks Cardiomyocyte Autophagic Flux by Inhibiting Lysosome Acidification.

Authors:  Dan L Li; Zhao V Wang; Guanqiao Ding; Wei Tan; Xiang Luo; Alfredo Criollo; Min Xie; Nan Jiang; Herman May; Viktoriia Kyrychenko; Jay W Schneider; Thomas G Gillette; Joseph A Hill
Journal:  Circulation       Date:  2016-03-16       Impact factor: 29.690

Review 7.  Chaperones in autophagy.

Authors:  Susmita Kaushik; Ana Maria Cuervo
Journal:  Pharmacol Res       Date:  2012-10-08       Impact factor: 7.658

8.  Salmeterol enhances the cardiac response to gene therapy in Pompe disease.

Authors:  Sang-Oh Han; Songtao Li; Dwight D Koeberl
Journal:  Mol Genet Metab       Date:  2016-03-18       Impact factor: 4.797

9.  MAP1LC3B overexpression protects against Hermansky-Pudlak syndrome type-1-induced defective autophagy in vitro.

Authors:  Saket Ahuja; Lars Knudsen; Shashi Chillappagari; Ingrid Henneke; Clemens Ruppert; Martina Korfei; Bernadette R Gochuico; Saverio Bellusci; Werner Seeger; Matthias Ochs; Andreas Guenther; Poornima Mahavadi
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-12-30       Impact factor: 5.464

10.  Pharmacological enhancement of α-glucosidase by the allosteric chaperone N-acetylcysteine.

Authors:  Caterina Porto; Maria C Ferrara; Massimiliano Meli; Emma Acampora; Valeria Avolio; Margherita Rosa; Beatrice Cobucci-Ponzano; Giorgio Colombo; Marco Moracci; Generoso Andria; Giancarlo Parenti
Journal:  Mol Ther       Date:  2012-09-18       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.